Formulated for erectile dysfunction to manage blood flow and support physiological response during stimulation.
Mechanism of Action
This medication inhibits the phosphodiesterase type 5 enzyme, which leads to increased levels of cyclic guanosine monophosphate. This biochemical process promotes smooth muscle relaxation and increased blood inflow to specific vascular tissues during sexual arousal.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
4–6 hours
Contraindications
Concurrent use of nitrates, Hypersensitivity to sildenafil, Severe cardiovascular disease
Severe Adverse Events
Priapism, Sudden loss of vision, Myocardial infarction — requires immediate medical attention
Information related to Vidalista Yellow is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
